melatonin receptor agonists
Treatment of Non-24–Hour Sleep-Wake Disorder (a circadian rhythm disorder more common in totally blind patients).
Acts as an agonist at melatonin MT1 and MT2 receptor sites, which are involved in regulation or circadian rhythm.
Improved circadian rhythm with improved sleep/wake patterns.
Absorption: 38% absorbed following oral administration, blood levels are ↑ in female patients.
Metabolism and Excretion: Extensively metabolized mostly by CYP1A2 and also CYP3A4, metabolited do not contribute significantly to pharmacological effect. Metabolites are primarily excreted in urine, less than 1% as unchanged drug), 4% excreted in feces.
Half-life: 1.3 hr.
TIME/ACTION PROFILE (establishment of circadian rhythm/sleep cycle)
- Severe hepatic impairment.
Use Cautiously in:
- Concurrent use of strong CYP1A2 inducers/inhibitors (may alter drug effects)
- Geri: ↑ risk of adverse reactions due to ↑ blood levels;
- OB: May cause fetal harm, use only if potential benefit justifies potential fetal risk;
- Lactation: Use cautiously if breastfeeding;
- Pedi: Safety and effectiveness not established.
Adverse Reactions/Side Effects
CNS: headache, nightmares/unusual dreams
GI: ↑ liver enzymes
* CAPITALS indicate life-threatening.
Underline indicate most frequent.
PO (Adults) 20 mg at bedtime, taken at the same time every day.
Capsules: 20 mg
- Assess mental status, sleep patterns, and frequency of daytime naps prior and periodically during therapy.
Lab Test Considerations:
May cause ↑ transaminases.
- Readiness for enhanced sleep (Indications)
- PO Administer without food before bedtime at the same time each night. Swallow capsule whole; do not open, dissolve, crush, or chew.
- Instruct patient to take tasimelteon as directed at the same time each day. If unable to take at approximately the same time on a given night, skip dose and resume following night. After taking, advise patient to limit activity to preparing to go to bed.
- Caution patient tasimelteon can impair performance of activities requiring complete mental alertness. Advise patient to avoid driving and other activities requiring alertness after taking tasimelteon.
- Advise female patient to notify health care professional if pregnancy is planned or suspected or if breastfeeding
Improved circadian rhythm with improved sleep/wake patterns. Due to differences in circadian rhythms, may require daily use for several wks or mo before benefit from tasimelteon is noticeable.
Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Complete Product Information.